781
Views
11
CrossRef citations to date
0
Altmetric
Drug Evaluation

Pembrolizumab for the treatment of diffuse large B-cell lymphoma

&
Pages 1119-1126 | Received 03 Apr 2019, Accepted 21 Aug 2019, Published online: 28 Aug 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Salvatore Perrone, Paolo Lopedote, Mario Levis, Alice Di Rocco & Stephen Douglas Smith. (2022) Management of relapsed or refractory large B-cell lymphoma in patients ineligible for CAR-T cell therapy. Expert Review of Hematology 15:3, pages 215-232.
Read now
Mattia Novo, Elisa Santambrogio, Pio Manlio Mirko Frascione, Delia Rota-Scalabrini & Umberto Vitolo. (2021) Antibody Therapies for Large B-Cell Lymphoma. Biologics: Targets and Therapy 15, pages 153-174.
Read now

Articles from other publishers (9)

Qingzhu Jia, Aoyun Wang, Yixiao Yuan, Bo Zhu & Haixia Long. (2022) Heterogeneity of the tumor immune microenvironment and its clinical relevance. Experimental Hematology & Oncology 11:1.
Crossref
Yanan Jiang, Huimeng Sun, Hong Xu, Xin Hu, Wenqi Wu, Yangyang Lv, Jinhuan Wang, Su Liu, Yixin Zhai, Linyan Tian, Yafei Wang & Zhigang Zhao. (2022) Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma. Frontiers in Genetics 13.
Crossref
Sicong Wang, Giovanna Di Trapani & Kathryn F. Tonissen. (2022) Expanding the armory for treating lymphoma: Targeting redox cellular status through thioredoxin reductase inhibition. Pharmacological Research 177, pages 106134.
Crossref
Yujia Zhai, Xiangxiang Zhou & Xin Wang. (2022) Novel insights into the biomarkers and therapies for primary central nervous system lymphoma. Therapeutic Advances in Medical Oncology 14, pages 175883592210937.
Crossref
Andriani Charalambous & Mark-Alexander Schwarzbich. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 42 .
Faroogh Marofi, Heshu Sulaiman Rahman, Muhammad Harun Achmad, Klunko Nataliya Sergeevna, Wanich Suksatan, Walid Kamal Abdelbasset, Maria Vladimirovna Mikhailova, Navid Shomali, Mahboubeh Yazdanifar, Ali Hassanzadeh, Majid Ahmadi, Roza Motavalli, Yashwant Pathak, Sepideh Izadi & Mostafa Jarahian. (2021) A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions. Frontiers in Immunology 12.
Crossref
Marc Armengol, Juliana Carvalho Santos, Miranda Fernández-Serrano, Núria Profitós-Pelejà, Marcelo Lima Ribeiro & Gaël Roué. (2021) Immune-Checkpoint Inhibitors in B-Cell Lymphoma. Cancers 13:2, pages 214.
Crossref
Liang Wang, Lin-rong Li & Ken H. Young. (2020) New agents and regimens for diffuse large B cell lymphoma. Journal of Hematology & Oncology 13:1.
Crossref
Wei Xie, L. Jeffrey Medeiros, Shaoying Li, C. Cameron Yin, Joseph D. Khoury & Jie Xu. (2020) PD-1/PD-L1 Pathway and Its Blockade in Patients with Classic Hodgkin Lymphoma and Non-Hodgkin Large-Cell Lymphomas. Current Hematologic Malignancy Reports 15:4, pages 372-381.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.